[Federal Register Volume 61, Number 192 (Wednesday, October 2, 1996)] [Notices] [Page 51434] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-25194] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE National Institute of Standards and Technology Notice of Prospective Grant of Coexclusive Patent License SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i) that the National Institute of Standards and Technology (``NIST''), U.S. Department of Commerce, is contemplating the grant of a field of use coexclusive license in the United States to practice the invention embodied in U.S. Patent Number 5,389,523, titled, ``Liposome Immunoanalysis By Flow Injection Assay'' to Pasadena Scientific Industries, having a place of business in Hanover, Maryland and Saddleback Aerospace Corporation, having a place of business in Issaquah, Washington. FOR FURTHER INFORMATION CONTACT: Bruce E. Mattson, National Institute of Standards and Technology, Industrial Partnerships Program, Building 820, Room 213, Gaithersburg, MD 20899. SUPPLEMENTARY INFORMATION: The prospective coexclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective coexclusive license may be granted unless, within sixty days from the date of this published Notice, NIST receives written evidence and argument which establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. U.S. Patent Number 5,389,523 is a method of immunoanalysis which combines immobilized immunochemistry with the technique of flow injection analysis, and employs microscopic spherical structures called liposomes, or lipid vesicles, as carriers of detectable reagents. NIST may enter into a Cooperative Research and Development Agreement (``CRADA'') with the licensees to perform further research on the invention for purposes of commercialization. NIST may grant the licensees an option to negotiate for coexclusive licenses to any jointly owned inventions which arise from the CRADA as well as an option to negotiate for coexclusive royalty-bearing licenses for NIST employee inventions which arise from the CRADA. The availability of the invention for licensing was published in the Federal Register, Vol. 57, No. 226 (November 23, 1992). A copy of the patent application may be obtained from NIST at the foregoing address. Dated: September 24, 1996. Samuel Kramer, Associate Director. [FR Doc. 96-25194 Filed 10-1-96; 8:45 am] BILLING CODE 3510-13-M